Related Experiment Video
Updated: Jan 18, 2026

10:27
Murine Heterotopic Heart Transplant Technique
Published on: July 8, 2014
17.6K
Mixed Cellular and Antibody-Mediated Rejection-A Rare yet Morbid Occurrence
Cristina Chiodi1, Harsh Tiwari1, Esther Bak1
1Department of Internal Medicine, University of Louisville, Louisville, KY.
ACG Case Reports Journal
|September 8, 2025
Summary
This case study details a rare dual rejection following liver transplantation, involving both cellular and antibody-mediated rejection. Prompt diagnosis and intensified immunosuppression were crucial for managing this complex post-transplant complication.
Area of Science:
- Immunology
- Transplantation Medicine
- Hepatology
Background:
- Liver transplantation is the primary treatment for end-stage liver disease.
- Graft rejection remains a major obstacle to long-term transplant success.
- Primary sclerosing cholangitis is a common indication for liver transplantation.
Related Concept Videos
Cell-mediated Immune Responses
83.5K
Overview
83.5K
Tissue Transplantation
928
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
928
Bone Marrow Sampling and Transplants
910
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
910
Hybridoma Technology
17.3K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
17.3K
Kidney Transplant II: Surgical Procedure
325
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
325
Cross-reactivity
32.9K
Overview
32.9K

